Literature DB >> 10366649

Differential regulation of mPER1 and mTIM proteins in the mouse suprachiasmatic nuclei: new insights into a core clock mechanism.

M H Hastings1, M D Field, E S Maywood, D R Weaver, S M Reppert.   

Abstract

Recent discoveries have identified a framework for the core circadian clock mechanism in mammals. Development of this framework has been based entirely on the expression patterns of so-called "clock genes" in the suprachiasmatic nuclei (SCN), the principal clock of mammals. We now provide data concerning the protein expression patterns of two of these genes, mPer1 and mTim. Our studies show that mPER1 and mTIM are nuclear antigens expressed in the SCN and extensively throughout the forebrain. Expression of mPER1 in the SCN was rhythmic under entrained conditions and with clear circadian cycling under free-running conditions. Expression of mPER1 elsewhere in the mouse forebrain was not rhythmic. In contrast to mPER1, mTIM expression in the SCN did not vary with time in mice housed in either a light/dark cycle or in constant dim red light. The phase relationship between mPer1 RNA and mPER1 cycles in the SCN is consistent with a negative feedback model of the mammalian clock. The invariant nature of nuclear mTIM in the SCN suggests that its participation in negative feedback occurs only after mPER1 has entered the nucleus, and that the abundance of mTIM is not regulated by the circadian clock or the light/dark cycle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10366649      PMCID: PMC6782673     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  46 in total

1.  Molecular clocks (joint Juan March/EMBO workshop). Madrid, May 10-12, 1999.

Authors:  N S Foulkes; P Sassone-Corsi
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

2.  Circadian clock-protein expression in cyanobacteria: rhythms and phase setting.

Authors:  Y Xu; T Mori; C H Johnson
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

3.  Dimerization and nuclear entry of mPER proteins in mammalian cells.

Authors:  K Yagita; S Yamaguchi; F Tamanini; G T van Der Horst; J H Hoeijmakers; A Yasui; J J Loros; J C Dunlap; H Okamura
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

4.  Two novel doubletime mutants alter circadian properties and eliminate the delay between RNA and protein in Drosophila.

Authors:  V Suri; J C Hall; M Rosbash
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

5.  Light and glutamate-induced degradation of the circadian oscillating protein BMAL1 during the mammalian clock resetting.

Authors:  T Tamaru; Y Isojima; T Yamada; M Okada; K Nagai; K Takamatsu
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

6.  Targeted disruption of the mPer3 gene: subtle effects on circadian clock function.

Authors:  L P Shearman; X Jin; C Lee; S M Reppert; D R Weaver
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

7.  The suprachiasmatic nucleus is a functionally heterogeneous timekeeping organ.

Authors:  Rae Silver; William J Schwartz
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

8.  Ube3a imprinting impairs circadian robustness in Angelman syndrome models.

Authors:  Shu-qun Shi; Terry Jo Bichell; Rebecca A Ihrie; Carl Hirschie Johnson
Journal:  Curr Biol       Date:  2015-02-05       Impact factor: 10.834

9.  Anatomical and functional characterization of clock gene expression in neuroendocrine dopaminergic neurons.

Authors:  Michael T Sellix; Marcel Egli; Maristela O Poletini; De'Nise T McKee; Matthew D Bosworth; Cheryl A Fitch; Marc E Freeman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-12-22       Impact factor: 3.619

10.  A short half-life GFP mouse model for analysis of suprachiasmatic nucleus organization.

Authors:  Joseph LeSauter; Lily Yan; Bhavana Vishnubhotla; Jorge E Quintero; Sandra J Kuhlman; Douglas G McMahon; Rae Silver
Journal:  Brain Res       Date:  2003-02-28       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.